Chemoinformaics analysis of 6beta-Hydroxystigmast-4-en-3-one
| Molecular Weight | 428.701 | nRot | 6 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 1 |
| Exact Molecular Weight | 428.365 | nRing | 4 |
| Solubility: LogS | -3.716 | nHRing | 0 |
| Solubility: LogP | 4.35 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 82.0401 |
| nHD | 1 | BPOL | 49.0219 |
| QED | 0.38 |
| Synth | 2.452 |
| Natural Product Likeliness | 0.812 |
| NR-PPAR-gamma | 0.51 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.523 |
| Pgp-sub | 0.737 |
| HIA | 0.011 |
| CACO-2 | -4.718 |
| MDCK | 0.0000364 |
| BBB | 0.457 |
| PPB | 0.944773 |
| VDSS | 0.731 |
| FU | 0.0356345 |
| CYP1A2-inh | 0.604 |
| CYP1A2-sub | 0.165 |
| CYP2c19-inh | 0.319 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.339 |
| CYP2c9-sub | 0.822 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.064 |
| CYP3a4-inh | 0.293 |
| CYP3a4-sub | 0.085 |
| CL | 9.205 |
| T12 | 0.786 |
| hERG | 0.15 |
| Ames | 0.038 |
| ROA | 0.021 |
| SkinSen | 0.868 |
| Carcinogencity | 0.133 |
| EI | 0.115 |
| Respiratory | 0.167 |
| NR-Aromatase | 0.217 |
| Antiviral | No |
| Prediction | 0.685598 |